治疗指导方针/建议,以法国多学科骨头原发性瘤工作组GroupOs的名义
Valentine Martin1, Stéphanie Bolle1, Line Claude2
1Radiation Oncology department, Gustave Roussy Cancer Center, Villejuif, France.
Bulletin du cancer
|March 11, 2025
概括
放射治疗在治疗抗辐射骨髓瘤中起着重要作用,特别是在手术后或无法切除的瘤时. 像立体辐射疗法这样的先进技术显示出对转移的前景.
科学领域:
- 在瘤学瘤学.
- 辐射瘤学 辐射瘤学
背景情况:
- 骨髓瘤的放射电阻是众所周知的.
- 目前的主要治疗方法包括化疗和手术.
研究的目的:
- 从2000年代起,审查放射治疗在骨髓瘤治疗中的作用.
- 为不同的临床场景定义最佳的放射治疗策略.
主要方法:
- 关于2000年以来发表的研究的文献综述.
- 在儿科和成人骨髓瘤病例中的放射治疗应用的分析.
主要成果:
- 术后放射治疗 (≥60Gy) 适用于R1切除.
- 更高的剂量用于无法切除的瘤.
- 子和立体辐射疗法显示出转移的潜力.
结论:
- 放射治疗在特定的骨髓瘤情况下是一个可行的选择.
- 在照射过程中,系统性治疗适应至关重要.
相关概念视频
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Osteoclasts in Bone Remodeling
2.8K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.8K
Fractures: Bone Repair
2.9K
Treatment for a fracture is based on the type of break, the bone affected, and the patient's age.
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
2.9K
Tumor Immunotherapy
457
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
457


